Consensus RaQualia Pharma Inc.

Equities

Market Closed - Japan Exchange Other stock markets 11:30:00 07/05/2024 am IST			5-day change	1st Jan Change
609 ^JPY	+1.67%		+2.35%	-11.48%

26/03	RaQualia Pharma Inc. completed the acquisition of FIMECS, Inc. from Yusuke Tominari, Kamakanae, Nissay Capital No. 11 Investment Limited Partnership managed by Nissay Capital Co., Ltd., ANRI No. 4 Fund managed by ANRI and others.	CI
14/02	RaQualia Pharma Inc. Provides Consolidated Earnings Guidance for the Year Ending December 31, 2024	CI

39af0.xPynm_KLnll7LzCR0tCzhwnC7VUWz3rFcza27kh32Qc.rb3_9Mv89jwRdQO8qOPmzT71jz9CrS2dNnn8tDAnt2-sv-zJkcrzHCtDZQ~490e7ae555eb1e8f963abcff6a7e2425

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

599 JPY

Average target price

1,800 JPY

Spread / Average Target

+200.50%

High Price Target

1,800 JPY

Spread / Highest target

+200.50%

Low Price Target

1,800 JPY

Spread / Lowest Target

+200.50%